GlassScriptPhysician profile
Barbara Anne Mcgrath
NPI 1932294188
$2,913.55
in general payments reported to CMS, 2019-2025
21 companies · $697 in 2025
The $697 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $214 · 2021: $132 · 2022: $77.01 · 2023: $765 · 2024: $430 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,892.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $569.07 | 2019-2024 | |
| Mentor Worldwide LLC | $328.77 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $249.28 | 2023-2025 | Durasorb Monofilament Mesh, Tcc-Ez |
| Musculoskeletal Transplant Foundation INC. | $235.42 | 2019-2023 | |
| Mesh Suture INC | $194.01 | 2024 | |
| Davol INC. | $163.00 | 2023 | Phasix Mesh |
| Avita Medical Americas, LLC | $149.93 | 2025 | Recell |
| Allergan, INC. | $139.62 | 2020-2021 | |
| Abbvie INC. | $124.84 | 2025 | |
| Innovation Technologies INC | $117.92 | 2023 | Irrisept |
| Polynovo North America LLC | $110.43 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $107.24 | 2025 | |
| Medline Industries LP | $89.72 | 2024-2025 | Medline Industries, INC. |
| Smith+Nephew, INC. | $74.93 | 2024-2025 | Collagenase Santyl |
| Tactile Systems Technology INC | $68.12 | 2025 | Nimbl, Flexitouch Plus |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $57.95 | 2025 | |
| Becton, Dickinson and Company | $50.89 | 2022 | |
| Mimedx Group, INC. | $31.20 | 2024 | |
| Kerecis Limited | $20.40 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Coloplast Corp | $18.36 | 2024 | |
| Glaxosmithkline, LLC. | $12.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Mcgrath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.